OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

The optimization of recombinant antibody production in Chinese hamster ovary (CHO) cells presents a paramount challenge for the biopharmaceutical industry. Various strategies are employed enhance antibody titer, including process parameter optimization, genetic engineering, and the use of perfusion processes. Fine-tuning growth parameters plays a